As people around the world mark Earth Day (April 22) with activities that protect the planet, our cells are busy safeguarding their own environment.
To keep themselves neat, tidy and above all healthy, cells rely on a variety of recycling and trash removal systems. If it weren't for these systems, cells could look like microscopic junkyards—and worse, they might not function properly. Scientists funded by the National Institutes of Health are therefore working to understand the cell's janitorial services to find ways to combat malfunctions.
Office of Biological and Environmental Research of the U.S. Department of Energy Office of Science.
When proteins enter the proteasome, they're chopped into bits for re-use.
Garbage Disposal and Recycling Plant
One of the cell's trash processors is called the proteasome. It breaks down proteins, the building blocks and mini-machines that make up many cell parts. The barrel-shaped proteasome disassembles damaged or unwanted proteins, breaking them into bits that the cell can re-use to make new proteins. In this way, the proteasome is just as much a recycling plant as it is a garbage disposal.
How does the cell know which proteins to keep and which to trash? The 2004 Nobel Prize in chemistry went to three scientists for answering that question. They found that the cell labels its refuse with a tiny protein tag called ubiquitin. Once a protein has the ubiquitin label, the proteasome can grab it, put it inside the barrel, break it down and release the pieces.
Because diseases like Alzheimer's involve the accumulation of excess proteins, researchers are trying to develop medicines to help the proteasome out. They hope such a treatment would keep brain cells clean and healthy.
Scientists are also interested in designing medicines that turn off the proteasome. Cancer cells, for instance, make a lot of abnormal proteins that their proteasomes have to remove. A proteasome-clogging medicine could prevent cancer cells from recycling their own garbage, leaving them without reusable resources for survival and growth. This is the approach behind the proteasome inhibitor drug bortezomib, which is used for the blood cancer multiple myeloma.
Proteins aren't the only type of cellular waste. Cells also have to recycle compartments called organelles when they become old and worn out. For this task, they rely on an organelle called the lysosome, which works like a cellular stomach. Containing acid and several types of digestive enzymes, lysosomes digest unwanted organelles in a process termed autophagy, from the Greek words for "self" and "eat." The multipurpose lysosome also processes proteins, bacteria and other "food" the cell has engulfed.
An inability to make one of the lysosomal enzymes can lead to a rare, life-threatening sickness called a lysosomal storage disease. There are more than 40 different lysosomal storage diseases, depending on the kind of trash that's unprocessed. These diseases can affect many organs, including the brain, heart and bones.
Lysosomes also gobble up viruses, an activity important to fighting infections. A drug that activates lysosomes protects mice from diseases like West Nile virus. It's possible that the same or similar medications might treat diseases in which cellular trash piles up, including Alzheimer's and other diseases of aging.
While cells mainly use proteasomes and lysosomes, they have a couple of other options for trash disposal.
Sometimes they simply hang onto their trash, performing the cellular equivalent of sweeping it under the rug. Scientists propose that the cell may pile all the unwanted proteins together in a glob called an aggregate to keep them from gumming up normal cellular machinery.
For example, a protein called islet amyloid polypeptide builds up in aggregates in the pancreas of people with type 2 diabetes. Other proteins form aggregates in certain brain diseases. Scientists are still trying to understand what these trash piles do and whether they're helpful or harmful.
If the garbage can't be digested by lysosomes, the cell can sometimes spit it out in a process called exocytosis. Once outside the cell, the trash may encounter enzymes that can take it apart, or it may simply form a garbage heap called a plaque. Unfortunately, these plaques outside the cell may be harmful, too.
The cell also has ways to toss out some poisons that get inside. This means that cancer cells may pump out cancer drugs that are meant to destroy them, and bacteria may do the same with antibiotics. Scientists are studying how these pumps work, looking for ways to keep the medicines inside where they can do their job.
Further study of the many ways cells take out the trash could lead to new approaches for keeping them healthy and preventing or treating disease.
Inside the Cell Booklet http://publications.nigms.nih.gov/insidethecell/
Shelly Pollard |
Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University
How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy